Anaxsys Technology Limited

Early Stage

Anaxsys is a medical device company that develops and markets innovative respiratory devices that meet clinical needs.   A number of product applications are under development based on Anaxsys' patented sensor technology.  These include patient monitoring, screening and diagnostics in the areas of vital signs, sleep apnoea, asthma and lung cancer.  Anaxsys' first product to market is respiR8, a continuous respiratory rate counter that provides an early indication of patient deterioration.

At the point of our initial investment, Anaxsys had already established a novel technology with clear benefits to GP’s and users over existing technology on its core product.  The business had a substantial IP position with wide freedom to operate and that IP was of interest across a wide range of potential applications.

The business has a wide shareholder base.  Our Investor Director is assisting the company formulate its licence strategy.  

Our Approach

What do we look for?

Our business is about forming long term relationships with exceptional entrepreneurs and becoming a trusted partner and supportive investor.

We look for companies with both the vision and potential to become ‘game changers’ and market leaders across a range of sectors.

learn more

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
LE19 4XT

Tel: 0116 238 8200